Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-185.92%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Vivani Medical, Inc.
Market Cap
$106.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$106.96M
Net Profit Margin
-4416.22%
TTM Avg
-2208.11%
3Y Avg
-1104.06%
5Y Avg
-736.04%
Market Cap
$106.98M
Net Profit Margin
-33.92%
TTM Avg
-11.74%
3Y Avg
-13.15%
5Y Avg
-11.88%
Market Cap
$107.09M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1332.08%
Market Cap
$107.17M
Net Profit Margin
-14.78%
TTM Avg
-35.00%
3Y Avg
-39.46%
5Y Avg
-38.67%
Market Cap
$109.14M
Net Profit Margin
-2955.63%
TTM Avg
-2231.78%
3Y Avg
-3480.44%
5Y Avg
-3216.57%
Market Cap
$104.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$104.26M
Net Profit Margin
-72.28%
TTM Avg
-110.67%
3Y Avg
-76.27%
5Y Avg
-63.46%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivani Medical, Inc. (VANI) | $106.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | -4416.22% | -2208.11% | -1104.06% | -736.04% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -33.92% | -11.74% | -13.15% | -11.88% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 0.00% | 0.00% | 0.00% | -1332.08% |
| Apyx Medical Corporation (APYX)vs › | $107.17M | -14.78% | -35.00% | -39.46% | -38.67% |
| Immunic, Inc. (IMUX)vs › | $106.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | -2955.63% | -2231.78% | -3480.44% | -3216.57% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -72.28% | -110.67% | -76.27% | -63.46% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -1583.10% |
| 2019-09-30 | -1606.78% |
| 2019-06-30 | -658.35% |
| 2019-03-31 | -859.93% |
| 2018-12-31 | -501.30% |
| 2018-09-30 | -379.43% |
| 2018-06-30 | -417.46% |
| 2018-03-31 | -999.28% |
| 2017-12-31 | -238.31% |
| 2017-09-30 | -417.14% |
| 2017-06-30 | -306.04% |
| 2017-03-31 | -748.07% |
| 2016-12-31 | -1450.35% |
| 2016-09-30 | -719.41% |
| 2016-06-30 | -820.06% |
| 2016-03-31 | -552.33% |
| 2015-12-31 | -231.72% |
| 2015-09-30 | -209.54% |
| 2015-06-30 | -184.98% |
| 2015-03-31 | -291.54% |
| 2014-12-31 | -893.10% |
| 2014-09-30 | -1254.34% |
| 2014-06-30 | -1233.26% |
| 2014-03-31 | -980.43% |
| 2013-12-31 | -1060.62% |
| 2013-09-30 | -2620.96% |
| 2013-06-30 | -1710.46% |
| 2013-03-31 | -1205.50% |
